These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8540025)

  • 1. Dose dependence of bacillus Calmette-Guerin on the prevention of autoimmune diabetes in syngeneic islet transplantation.
    Lakey JR; Singh B; Warnock GL; Elliott JF; Rajotte RV
    Transplant Proc; 1995 Dec; 27(6):3413. PubMed ID: 8540025
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant immunotherapy with Bacillus Calmette-Guerin prevents recurrence of diabetes in islet grafts transplanted into NOD mice.
    Lakey JR; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1994 Apr; 26(2):736. PubMed ID: 8171632
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of recurrence of insulin-dependent diabetes mellitus in islet cell-transplanted diabetic NOD mice using adjuvant therapy.
    Lakey JR; Wang T; Warnock GL; Singh B; Rajotte RV
    Transplant Proc; 1992 Dec; 24(6):2848. PubMed ID: 1465969
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-2 Microglobulin gene disruption prolongs murine islet allograft survival in NOD mice.
    Osorio RW; Ascher NL; Melzer JS; Stock PG
    Transplant Proc; 1994 Apr; 26(2):752. PubMed ID: 8171644
    [No Abstract]   [Full Text] [Related]  

  • 6. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent autoimmune islet transplant destruction by simultaneous kidney transplantation.
    Bartlett ST; Dirden B; Schweitzer EJ; Sheffield C; Hadley GA
    Transplant Proc; 1994 Apr; 26(2):737. PubMed ID: 8171633
    [No Abstract]   [Full Text] [Related]  

  • 10. Allograft of microencapsulated islets in agarose gel in streptozotocin-induced and nonobese diabetic mice.
    Iwata H; Takagi T; Yamashita K; Kobayashi K; Amemiya H
    Transplant Proc; 1992 Jun; 24(3):934. PubMed ID: 1604671
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
    Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
    J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand-mediated mechanisms are involved in autoimmune destruction of islet beta cells in non-obese diabetic mice.
    Suarez-Pinzon WL; Power RF; Rabinovitch A
    Diabetologia; 2000 Sep; 43(9):1149-56. PubMed ID: 11043861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.
    Korbutt GS; Suarez-Pinzon WL; Power RF; Rajotte RV; Rabinovitch A
    Diabetologia; 2000 Apr; 43(4):474-80. PubMed ID: 10819241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
    Lakey JR; Singh B; Warnock GL; Rajotte RV
    Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic islets transplanted into the thymus of newborn mice prevent diabetes and reduce insulitis in the NOD mouse.
    Nomura Y; Mullen Y; Stein E
    Transplant Proc; 1993 Feb; 25(1 Pt 2):963-4. PubMed ID: 8442281
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of diabetes incidence by intrathymic islet isografting in newborn NOD mice.
    Nomura Y; Stein E; Mullen Y
    Transplant Proc; 1992 Dec; 24(6):2903. PubMed ID: 1465992
    [No Abstract]   [Full Text] [Related]  

  • 20. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.